Freddy Del-Carpio

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Monitoring anticoagulation using the activated clotting time (ACT) in patients treated with heparin and undergoing percutaneous coronary intervention (PCI) is one of the most frequently used tests in invasive cardiology. However, despite its widespread use and guideline endorsement, uncertainty remains regarding the association of ACT with outcomes in(More)
  • 1